Foff Erin Pennock
Foff Erin Pennock, CMO, reported an open-market or private sale at MapLight Therapeutics, Inc. involving 15355.000000 shares for an estimated $124068.40. Reported holdings after the transaction were 296906.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 15, 2026
- Filing date
- Oct 16, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 312,261 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
MPLT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0002021233-26-000016 Voting Common Stock
- Transaction date
- Oct 15, 2026 Filed Oct 16, 2026, 09:00 PM · 1d delay
- Shares
- 15,355 sh $8.08 per share
- Estimated value
- -$124k Computed from shares × price
- Holdings after
- 296,906 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Medical Officer
- F1
Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer…
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.755 to $8.3732 inclusive. The Reporting Person undertakes to provi…
0 other transactions
0 recent txs